Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page
- Check6 days agoChange DetectedThe page now displays a Last Update Posted timestamp, and the label 'Last Update Posted (Estimated)' has been removed to clarify update timing. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision: v3.3.4 was released (replacing v3.3.3). There are no substantive changes to the study details or layout.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe Study Locations section was expanded to include numerous investigational sites in the US and internationally (Argentina, China, France, Japan, Mexico, Russia, South Korea, and more). This broadens recruitment geography.SummaryDifference2%

- Check64 days agoChange DetectedAdded a note clarifying that publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2. The previous PubMed-focused note and revision text (v3.2.0) were removed.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded a new publication citation to the Publications section (Kim BS et al., Am J Clin Dermatol, 2025) and removed a generic NIH funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check93 days agoChange DetectedAn updated last update timestamp and minor formatting changes are visible; core study details, eligibility criteria, locations, and outcomes remain unchanged.SummaryDifference0.3%

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.